Craig Hallum Has Lowered Expectations for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN) had its target price decreased by Craig Hallum from $21.00 to $18.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the construction company’s stock. Craig Hallum’s price target would indicate a potential upside of 100.78% from the company’s previous close.

Other research analysts have also issued reports about the stock. Piper Sandler lowered their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Saturday, February 8th. Canaccord Genuity Group cut their price target on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Finally, Barclays reduced their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and an average price target of $26.89.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $8.97 on Friday. The stock has a 50 day moving average of $12.36 and a two-hundred day moving average of $18.63. The stock has a market cap of $735.58 million, a P/E ratio of 897.40 and a beta of 2.14. Aspen Aerogels has a twelve month low of $8.43 and a twelve month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, research analysts forecast that Aspen Aerogels will post 0.12 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. nVerses Capital LLC lifted its position in Aspen Aerogels by 45.0% during the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares during the period. Quest Partners LLC lifted its holdings in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after acquiring an additional 5,361 shares during the period. Pursue Wealth Partners LLC purchased a new position in shares of Aspen Aerogels during the 3rd quarter worth about $222,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Aspen Aerogels in the third quarter worth approximately $252,000. Finally, Kovitz Investment Group Partners LLC purchased a new stake in Aspen Aerogels in the third quarter valued at approximately $263,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.